Elbendary A - Search Results

1

Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.

Elbendary A, Berchuck A, Davis P, Havrilesky L, Bast RC Jr, Iglehart JD, Marks JR. Elbendary A, et al. Cell Growth Differ. 1994 Dec;5(12):1301-7. Cell Growth Differ. 1994. PMID: 7696178

2

Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells.

Elbendary AA, Cirisano FD, Evans AC Jr, Davis PL, Iglehart JD, Marks JR, Berchuck A. Elbendary AA, et al. Clin Cancer Res. 1996 Sep;2(9):1571-5. Clin Cancer Res. 1996. PMID: 9816335

3

Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta.

Havrilesky LJ, Hurteau JA, Whitaker RS, Elbendary A, Wu S, Rodriguez GC, Bast RC Jr, Berchuck A. Havrilesky LJ, et al. Among authors: elbendary a. Cancer Res. 1995 Feb 15;55(4):944-8. Cancer Res. 1995. PMID: 7531618

4

Pathogenesis of ovarian cancers.

Berchuck A, Elbendary A, Havrilesky L, Rodriguez GC, Bast RC Jr. Berchuck A, et al. Among authors: elbendary a. J Soc Gynecol Investig. 1994 Jul-Sep;1(3):181-90. doi: 10.1177/107155769400100302. J Soc Gynecol Investig. 1994. PMID: 9419769

5

Chemotherapy-induced apoptosis in epithelial ovarian cancers.

Havrilesky LJ, Elbendary A, Hurteau JA, Whitaker RS, Rodriguez GC, Berchuck A. Havrilesky LJ, et al. Among authors: elbendary a. Obstet Gynecol. 1995 Jun;85(6):1007-10. doi: 10.1016/0029-7844(95)00058-y. Obstet Gynecol. 1995. PMID: 7770245

6

Co-expression of p53 by epithelial and stromal elements in carcinosarcoma of the female genital tract: an immunohistochemical study of 19 cases.

Szukala SA, Marks JR, Burchette JL, Elbendary AA, Krigman HR. Szukala SA, et al. Int J Gynecol Cancer. 1999 Mar;9(2):131-136. doi: 10.1046/j.1525-1438.1999.09905.x. Int J Gynecol Cancer. 1999. PMID: 11240754

7

Mutational analysis of the estrogen-receptor gene in endometrial carcinoma.

Kohler MF, Berkholz A, Risinger JI, Elbendary A, Boyd J, Berchuck A. Kohler MF, et al. Among authors: elbendary a. Obstet Gynecol. 1995 Jul;86(1):33-7. doi: 10.1016/0029-7844(95)00113-6. Obstet Gynecol. 1995. PMID: 7784019

8

Surgery for advanced ovarian cancer.

Clarke-Pearson DL, Kohler MF, Hurteau JA, Elbendary A. Clarke-Pearson DL, et al. Among authors: elbendary a. Clin Obstet Gynecol. 1994 Jun;37(2):439-60. doi: 10.1097/00003081-199406000-00019. Clin Obstet Gynecol. 1994. PMID: 7518370 Review. No abstract available.

9

Differences in patterns of TP53 and KRAS2 mutations in a large series of endometrial carcinomas with or without microsatellite instability.

Swisher EM, Peiffer-Schneider S, Mutch DG, Herzog TJ, Rader JS, Elbendary A, Goodfellow PJ. Swisher EM, et al. Among authors: elbendary a. Cancer. 1999 Jan 1;85(1):119-26. doi: 10.1002/(sici)1097-0142(19990101)85:1<119::aid-cncr17>3.0.co;2-5. Cancer. 1999. PMID: 9921983

10

Analysis of MSH3 in endometrial cancers with defective DNA mismatch repair.

Swisher EM, Mutch DG, Herzog TJ, Rader JS, Kowalski LD, Elbendary A, Goodfellow PJ. Swisher EM, et al. Among authors: elbendary a. J Soc Gynecol Investig. 1998 Jul-Aug;5(4):210-6. doi: 10.1016/s1071-5576(98)00016-1. J Soc Gynecol Investig. 1998. PMID: 9699180

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters